We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
-2.03%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
-$380M
(-13%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-8.45%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
106
New
13
Increased
24
Reduced
44
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$67.1M |
| 2 |
Cigna
CI
|
+$59.2M |
| 3 |
UnitedHealth
UNH
|
+$55.2M |
| 4 |
Humana
HUM
|
+$51.8M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$46.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$84.9M |
| 2 |
AbbVie
ABBV
|
+$69.8M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$57.9M |
| 4 |
Cencora
COR
|
+$57.7M |
| 5 |
argenx
ARGX
|
+$50.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
101
DELISTED
2seventy bio
TSVT
| – | – |
-1,342,000
| Closed | -$13.6M |
|
102
Vir Biotechnology
VIR
$1.46B
| – | – |
-1,425,000
| Closed | -$35M |
|
|
NARI
103
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-175,000
| Closed | -$10.2M |
|
|
EXAI
104
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| – | – |
-127,600
| Closed | -$755K |
|
|
AXNX
105
DELISTED
Axonics, Inc. Common Stock
AXNX
| – | – |
-379,700
| Closed | -$19.2M |
|
|
PNT
106
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-1,671,800
| Closed | -$15.1M |
|
Similar funds
NM
PWAM
LJAC
NI
MCM
TS
TW
PGA
Avidity Partners Management's Q3 2023 Portfolio in Review
As of Q3 2023, Avidity Partners Management held 106 positions worth $2.48B, down 13% from $2.86B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Avidity Partners Management withdrew a net $210M in Q3 2023, closing 23 positions and reducing 44 holdings. Its most notable exit was GE HealthCare, an estimated $84.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Technology.
Against the trend, Avidity Partners Management opened a new position in Cigna worth $59.4M.
- Avidity Partners Management's largest Q3 2023 buy was Cigna: 207,700 shares worth $59.4M.
- Avidity Partners Management added most to Boston Scientific in Q3 2023, an estimated $67.1M increase.
- Avidity Partners Management's biggest Q3 2023 reduction was argenx, cutting an estimated $50.7M.
- Avidity Partners Management fully exited GE HealthCare in Q3 2023, selling an estimated $84.9M.
- Avidity Partners Management's ten largest holdings make up 30% of its $2.48B portfolio in Q3 2023.
- Avidity Partners Management opened 13 new positions and closed 23 in Q3 2023.
- Avidity Partners Management's portfolio value fell 13% quarter-over-quarter to $2.48B.
Based on Avidity Partners Management's 13F filing for Q3 2023, filed 14 Nov 2023.